Clinical Trial Update: BIBW 2992 (Afatinib) and Vinorelbine [Phase 2]

View source ↗

Summary

Phase 2 trial of afatinib (BIBW 2992) in combination with vinorelbine for stage IV breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Afatinib (afatinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: University of Magdeburg | Conditions: Carcinoma Breast Stage IV | Phase 2 | Status: TERMINATED